Back to top

Image: Bigstock

Zacks.com featured highlights Archer-Daniels-Midland, Agilent Technologies, Republic Services, Deere and Cardinal Health

Read MoreHide Full Article

For Immediate Release

Chicago, IL – February 2, 2023 – Stocks in this week’s article are Archer-Daniels-Midland Co. (ADM - Free Report) , Agilent Technologies (A - Free Report) , Republic Services Inc. (RSG - Free Report) , Deere & Co. (DE - Free Report) and Cardinal Health Inc. (CAH - Free Report) .

5 Top Dividend Growth Stocks to Buy in the Month of Love

Dividend investing has remained the hottest segment of the stock market over the past year. Though U.S. stocks have resumed their strength this year on easing inflation and the Fed’s slower rate hike bets, recession worries persist. In such a scenario, dividends are major sources of consistent income for investors though they do not offer dramatic price appreciation. Stocks backed by regular dividends can reduce the volatility of a portfolio and tend to outperform in a choppy market.

In particular, focusing on the growth level in this strategy leads to higher returns. Honing in on stocks with a history of dividend growth leads to a healthy portfolio, with a greater scope of capital appreciation, as opposed to simple dividend-paying stocks or those with high yields.

We have selected five dividend growth stocks — Archer-Daniels-Midland Co., Agilent Technologies, Republic Services Inc., Deere & Co. and Cardinal Health Inc. — that investors would love to buy this month.

Why is Dividend Growth Better?

Stocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.

Additionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that dividend increase is likely in the future.

Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.

Here are five of the 21 stocks that fit the bill:

Illinois-based Archer-Daniels is one of the leading producers of food and beverage ingredients as well as goods made from various agricultural products. ADM delivered an average earnings surprise of 28.07%.

Archer-Daniels has a Zacks Rank #1 and a Growth Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.

California-based Agilent Technologies is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. The company has an estimated earnings growth rate of 8% for the fiscal year (ending October 2023) and delivered an average earnings surprise of 6.74% for the past four quarters.

Currently, A has a Zacks Rank #2 and a Growth Score of B.

Arizona-based Republic Services is the second largest provider of non-hazardous solid waste collection, transfer, disposal, recycling, and energy services in the United States. It has an estimated earnings growth rate of 5.4%.

Republic Services has a Zacks Rank #2 and a Growth Score of B.

Illinois-based Deere & Company is the world’s largest producer of agricultural equipment, manufacturing agricultural machinery since 1837 under the iconic John Deere brand with its signature green and yellow color scheme. The stock saw a solid earnings estimate revision of 3 cents over the past 30 days for the fiscal year (ending October 2023) and has an estimated earnings growth rate of 20.3%.

Deere & Company carries a Zacks Rank #2 and a Growth Score of A.

Ohio-based Cardinal Health is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has an estimated earnings growth rate of 4.7% for the fiscal year (ending June 2023).

Cardinal Health has a Zacks Rank #2 and a Growth Score of B.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2047508/5-top-dividend-growth-stocks-to-buy-in-the-month-of-love

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://www.twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance  for information about the performance numbers displayed in this press release.

Published in